Literature DB >> 28965088

Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models.

Wendy W Weston1,2, Vesna Jurecic1, Roland Jurecic3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28965088      PMCID： PMC5622846          DOI： 10.3324/haematol.2017.175497

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

Review 1.  Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.

Authors:  Antonio M Risitano
Journal:  Curr Opin Hematol       Date:  2012-01       Impact factor: 3.284

2.  Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.

Authors:  Phillip Scheinberg; Colin O Wu; Olga Nunez; Priscila Scheinberg; Carol Boss; Elaine M Sloand; Neal S Young
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

Review 3.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 4.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 5.  Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.

Authors:  Andrea Bacigalupo; Sabrina Giammarco; Simona Sica
Journal:  Int J Hematol       Date:  2016-06-08       Impact factor: 2.490

Review 6.  Animal models for acquired bone marrow failure syndromes.

Authors:  Jichun Chen
Journal:  Clin Med Res       Date:  2005-05

Review 7.  Recent advances in understanding clonal haematopoiesis in aplastic anaemia.

Authors:  Natasha Stanley; Timothy S Olson; Daria V Babushok
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

Review 8.  Aplastic anemia: what have we learned from animal models and from the clinic.

Authors:  Phillip Scheinberg; Jichun Chen
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

Review 9.  Clonal hematopoiesis in acquired aplastic anemia.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2016-04-27       Impact factor: 22.113

Review 10.  Eltrombopag for the treatment of aplastic anemia: current perspectives.

Authors:  Su Han Lum; John D Grainger
Journal:  Drug Des Devel Ther       Date:  2016-09-13       Impact factor: 4.162
View more
  3 in total

1.  Interferon gamma inhibits the differentiation of mouse adult liver and bone marrow hematopoietic stem cells by inhibiting the activation of notch signaling.

Authors:  Yuhong Qin; Keke Fang; Nan Lu; Yuan Hu; Zhigang Tian; Cai Zhang
Journal:  Stem Cell Res Ther       Date:  2019-07-16       Impact factor: 6.832

2.  Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report.

Authors:  Haiyue Niu; Weiwei Qi; Yihao Wang; Limin Xing; Rong Fu; Zonghong Shao; Huaquan Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

3.  The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure.

Authors:  Shaoxue Ding; Xiaowei Liang; Tian Zhang; Rong Fu
Journal:  J Immunol Res       Date:  2020-10-17       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.